Clinical Lymphoma Myeloma & Leukemia · 2022 · 10 citations · 13 references
MedicineOncologyPharmacotherapyHematologic OncologyImmuno-oncology PharmacotherapyTumor ImmunologyCancer ImmunotherapyHematologic MalignanciesHematologic Malignancy PharmacotherapyHematologic Malignancy TherapyHematopoietic NeoplasmsMultiple MyelomaCase Series ReviewMultiple Myeloma TherapyMultiple Myeloma TreatmentMyeloid NeoplasmsRelapsed Multiple Myeloma
13
A conserved dendritic-cell regulatory program limits antitumour immunity
Bárbara Maier, Andrew M. Leader, Steven T. Chen et al. · Nature · 2020 · 935 citations · Full text
Life Sciences, Immunology, Oncology +12
Lucia De Monte, Michele Reni, Elena Tassi et al. · The Journal of Experimental Medicine · 2011 · 692 citations · Full text
Medicine, Immunology, Oncology +15
Treatment Outcomes of Immune-Related Cutaneous Adverse Events
Gregory S. Phillips, Jennifer Wu, Matthew D. Hellmann et al. · Journal of Clinical Oncology · 2019 · 235 citations · Full text
Medicine, Dermatology, Immunology +17